Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tefferi

Showing results (221-230 of 346) with videos related to

Pageof 35
Sort By:
Leukemia & Lymphoma|August 1, 1994
Detection of trisomy 12 by FISH in untreated B-chronic lymphocytic leukemia: correlation with stage and CD20 antigen expression intensityT E Witzig, T J Borell, J F Herath, et al.
Leukemia|May 30, 2008
5-Azacitidine has limited therapeutic activity in myelofibrosisR A Mesa, S Verstovsek, C Rivera, et al.
American Journal of Clinical Pathology|October 1, 1996
Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemiaA Tefferi, B J Bartholmai, T E Witzig, et al.
British Journal of Haematology|June 1, 1996
Spectrum of diseases associated with increased proportions or absolute numbers of peripheral blood natural killer cellsS H Okuno, A Tefferi, C A Hanson, et al.
Leukemia|September 14, 2011
IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromesA Pardanani, C Finke, T L Lasho, et al.
Leukemia Research|April 3, 2007
Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosisM A Elliott, S Verstovsek, D Dingli, et al.
Lancet (London, England)|August 23, 2003
Imatinib for systemic mast-cell diseaseA Pardanani, M Elliott, T Reeder, et al.
Leukemia|October 23, 2009
The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status-clinical correlates in a study of 226 consecutive patientsA Pardanani, T L Lasho, C M Finke, et al.
Leukemia|July 3, 2002
Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemiaL F Porrata, M R Litzow, A Tefferi, et al.
Blood Cancer Journal|April 22, 2017
Liver function test abnormalities and their clinical relevance in primary myelofibrosisD Barraco, M Mudireddy, S Shah, et al.
Pageof 35

Showing results (221-230 of 346) with videos related to

Sort By:
Pageof 35
Leukemia & Lymphoma|August 1, 1994
Detection of trisomy 12 by FISH in untreated B-chronic lymphocytic leukemia: correlation with stage and CD20 antigen expression intensityT E Witzig, T J Borell, J F Herath, et al.
Leukemia|May 30, 2008
5-Azacitidine has limited therapeutic activity in myelofibrosisR A Mesa, S Verstovsek, C Rivera, et al.
American Journal of Clinical Pathology|October 1, 1996
Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemiaA Tefferi, B J Bartholmai, T E Witzig, et al.
British Journal of Haematology|June 1, 1996
Spectrum of diseases associated with increased proportions or absolute numbers of peripheral blood natural killer cellsS H Okuno, A Tefferi, C A Hanson, et al.
Leukemia|September 14, 2011
IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromesA Pardanani, C Finke, T L Lasho, et al.
Leukemia Research|April 3, 2007
Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosisM A Elliott, S Verstovsek, D Dingli, et al.
Lancet (London, England)|August 23, 2003
Imatinib for systemic mast-cell diseaseA Pardanani, M Elliott, T Reeder, et al.
Leukemia|October 23, 2009
The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status-clinical correlates in a study of 226 consecutive patientsA Pardanani, T L Lasho, C M Finke, et al.
Leukemia|July 3, 2002
Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemiaL F Porrata, M R Litzow, A Tefferi, et al.
Blood Cancer Journal|April 22, 2017
Liver function test abnormalities and their clinical relevance in primary myelofibrosisD Barraco, M Mudireddy, S Shah, et al.
Pageof 35